After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Alkermes plc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Alkermes plc is $4.89B. A total of 2.31 million shares were traded on the day, compared to an average of 2.28M shares.
In the most recent transaction, Hopkinson Craig C. bought 5,000 shares of ALKS for 30.00 per share on Jan 08 ’26. In a previous transaction on Jan 08 ’26, Hopkinson Craig C. sold 5,000 shares at 30.00 per share. ALKS shares that EVP R&D, Chief Medical Officer owns now total 61,740.
Among the insiders who sold shares, Hopkinson Craig C. disposed of 4,000 shares on Jan 02 ’26 at a per-share price of $28.00. This resulted in the EVP R&D, Chief Medical Officer holding 61,740 shares of ALKS after the transaction. In another insider transaction, Hopkinson Craig C. bought 4,000 shares at $28.00 per share on Jan 02 ’26.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ALKS has a high of $36.45 and a low of $25.17.
As of this writing, ALKS has an earnings estimate of $0.4 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of $0.5 per share and a lower estimate of $0.29. The company reported an EPS of $1.05 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ALKS’s latest balance sheet shows that the firm has $536.31M in Cash & Short Term Investments as of fiscal 2021. There were $416.21M in debt and $471.29M in liabilities at the time. Its Book Value Per Share was $10.50, while its Total Shareholder’s Equity was $1.11B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALKS is Buy with a score of 4.47.
